These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9859148)
41. Anticoagulants in the prevention of embolic stroke. Part I. Wessler S Geriatrics; 1987 Feb; 42(2):29-35. PubMed ID: 3542723 [TBL] [Abstract][Full Text] [Related]
42. [Prevention of a brain infarct in patients with non-rheumatic atrial fibrillation]. Koudstaal PJ Ned Tijdschr Geneeskd; 1989 Jul; 133(30):1485-6. PubMed ID: 2677767 [No Abstract] [Full Text] [Related]
43. [Paroxysmal atrial fibrillation and cerebral embolisms]. Stenzinger W; Van de Loo J Dtsch Med Wochenschr; 1992 Apr; 117(17):680-1. PubMed ID: 1572252 [No Abstract] [Full Text] [Related]
44. [Cerebral infarctions. Study of their prevention]. Gautier JC; Morelot D Nouv Presse Med; 1975 Oct; 4(36):2575-80. PubMed ID: 1202432 [TBL] [Abstract][Full Text] [Related]
45. [Therapeutic ranges of oral anticoagulant therapy in different diseases. Guidelines of the Federation of Centers of Surveillance of Patients on Anticoagulation. Ad hoc Study Group]. Prisco D; Poli D; Palareti G Ann Ital Med Int; 1996; 11(3):196-203. PubMed ID: 8998265 [TBL] [Abstract][Full Text] [Related]
46. Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants. de Freitas AS; Alvarez-Larrán A Ann Hematol; 2016 Oct; 95(11):1903-4. PubMed ID: 27518531 [No Abstract] [Full Text] [Related]
47. [Cerebral-cardiac embolism. Cerebrovascular-cardiac embolic stroke]. Henriques I Acta Med Port; 1997; 10(8-9):597-602. PubMed ID: 9446480 [TBL] [Abstract][Full Text] [Related]
48. [The role of cardiac disease in the causation of cerebrovascular syndromes (author's transl)]. Kröss R; Knittel B; Thurnher G Wien Klin Wochenschr; 1981 Jun; 93(12):395-7. PubMed ID: 7269620 [TBL] [Abstract][Full Text] [Related]
49. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Lancet; 1994 Feb; 343(8896):499-503. PubMed ID: 7906757 [TBL] [Abstract][Full Text] [Related]
50. [Late sequelae of strokes based on registry data]. Riabova VS Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):532-6. PubMed ID: 3716702 [TBL] [Abstract][Full Text] [Related]
51. Kinetic study of factor X during oral anticoagulation with acenocoumarol: potential value for the initiation of treatment. Aiach M; Fiessinger JN; Capron L; Nussas C; Housset E; Leclerc M Thromb Haemost; 1982 Feb; 47(1):69-71. PubMed ID: 7071808 [No Abstract] [Full Text] [Related]
52. [Major hemorrhages associated with long-term treatment with acenocoumarol in patients with venous thromboembolic disease in a rural area of Extremadura (Spain)]. Calvo Romero JM Med Clin (Barc); 2005 Jun; 125(2):76-7. PubMed ID: 15970189 [No Abstract] [Full Text] [Related]
53. [Secondary prevention of cerebral embolism during non-valvular atrial fibrillation]. Laplane D Rev Prat; 1988 Jun; 38(18):1190-2. PubMed ID: 3175484 [No Abstract] [Full Text] [Related]
54. [Cerebral embolism. A neurologist's point of view]. Gautier JC Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):507-12. PubMed ID: 6529129 [TBL] [Abstract][Full Text] [Related]
58. [What patients with cerebrovascular embolism of cardiac origin should be anticoagulated?]. Eng-Ceceña L; Trejo-Gutiérrez JF; García-Ramos G Rev Invest Clin; 1985; 37(2):147-51. PubMed ID: 4035122 [No Abstract] [Full Text] [Related]
59. [A study of the incidence and hospital follow-up of epistaxis in patients treated with anticoagulant acenocoumarol]. García Callejo FJ; Velert Vila MM; Orts Alborch MH; Monzó Gandía R; Pardo Mateu L; Rubio Escolano F; Marco Algarra J Acta Otorrinolaringol Esp; 1997; 48(5):358-62. PubMed ID: 9376156 [TBL] [Abstract][Full Text] [Related]